| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.68▲ | 3.56▲ | 3.50▲ | 3.26▲ | 3.18▲ |
| MA10 | 3.47▲ | 3.30▲ | 3.23▲ | 3.02▲ | 5.09▼ |
| MA20 | 3.23▲ | 3.10▲ | 3.05▲ | 3.05▲ | 6.70▼ |
| MA50 | 2.95▲ | 2.93▲ | 2.89▲ | 5.42▼ | 9.72▼ |
| MA100 | 2.93▲ | 3.01▲ | 3.05▲ | 6.82▼ | 14.65▼ |
| MA200 | 3.07▲ | 4.22▼ | 5.53▼ | 9.00▼ | 23.64▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.065▲ | 0.084▲ | 0.093▲ | 0.243▲ | -0.338▼ |
| RSI | 76.212▲ | 75.874▲ | 74.755▲ | 52.558▲ | 41.059▼ |
| STOCH | 98.764▲ | 94.735▲ | 84.670▲ | 73.917 | 4.903▼ |
| WILL %R | -2.907▲ | -2.660▲ | -2.577▲ | -6.944▲ | -88.777▼ |
| CCI | 114.175▲ | 150.226▲ | 174.461▲ | 195.523▲ | -57.761 |
|
Wednesday, October 28, 2026 06:09 AM
New patents awarded in the US, Canada, and Europe * IP protection for treatments for Epilepsy, Diabetes, and HypertensionKELOWNA, BC / ACCESS Newswire / October 28, 2026 / (Nasdaq:LEXX) (the "Company" ...
|
|
Friday, July 17, 2026 12:54 PM
We update our report on Lexaria Bioscience Corporation (NASDAQ: LEXX) on the occasion of its third quarter fiscal 2026 Form 10-Q filing. Beyond the financial update, management elaborated on its ...
|
|
Thursday, January 11, 2024 05:30 AM
With each new study, the horizon of GLP-1's therapeutic potential expands, painting a vibrant picture of a future where a single molecule could tackle a multitude of human afflictions, including ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/10/26 | 3.38 | 3.87 | 3.30 | 3.77 | 38,984 |
| 28/10/26 | 3.18 | 3.55 | 3.065 | 3.30 | 38,919 |
| 27/10/26 | 3.10 | 3.31 | 2.96 | 3.22 | 41,763 |
| 26/10/26 | 3.08 | 3.08 | 2.83 | 2.92 | 13,831 |
| 23/10/26 | 2.98 | 3.199 | 2.84 | 3.08 | 23,200 |
| 22/10/26 | 2.74 | 2.99 | 2.5101 | 2.99 | 16,512 |
| 21/10/26 | 2.68 | 2.89 | 2.5157 | 2.82 | 28,670 |
| 20/10/26 | 2.60 | 2.68 | 2.51 | 2.65 | 41,909 |
| 19/10/26 | 2.79 | 2.79 | 2.4301 | 2.60 | 43,364 |
| 16/10/26 | 3.19 | 3.24 | 2.81 | 2.86 | 123,322 |
|
|
||||
|
|
||||
|
|